The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer

Chen, Bifeng; Jiao, Yuwei; Yaolong, Fukang; Li, Tiansong; Liu, Yu-Xiao; Wang, Meiqin; Gu, Xiaoqing; Feng, Xianhong

doi:10.1016/j.prp.2019.02.015

Cited by 16 publications

(11 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Compared with CC and TC genotypes, TT genotype carriers have a higher risk of cervical cancer (22). These studies show that lncRNA polymorphism is closely related to the risk of cervical cancer in women.…”

Section: Discussionmentioning

confidence: 59%

Autophagy-related long non-coding RNA signature for potential prognostic biomarkers of patients with cervical cancer: a study based on public databases

Feng¹,

Wang²,

Cui³

et al. 2021

Ann Transl Med

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 59%

Autophagy-related long non-coding RNA signature for potential prognostic biomarkers of patients with cervical cancer: a study based on public databases

Feng¹,

Wang²,

Cui³

et al. 2021

Ann Transl Med

View full text Add to dashboard Cite

“…Rs3787016, localizes to the fourth intron of RNA polymerase II polypeptide E (POLR2E) 16 gene, has been investigated by several researchers on its association with cancer risk [16,[30][31][32][33][34][35][36][37].The most important function of LncRNAs is involvement in the transcriptional or posttranscriptional regulation of gene expression [38]. Abnormal expressions of these RNAs facilitate tumor-cell proliferation, invasion and survival in cancer development and progression [39][40][41].…”

Section: Discussionmentioning

confidence: 99%

Association of rs3746444 in MiRNA-499 and rs3787016 in Long Non-coding RNAs POLR2E with Prostate Cancer: an updated meta-analysis and systematic review

Liu

Wang

et al. 2020

Preprint

View full text Add to dashboard Cite

Background It has been proved that a significant proportion of prostate cancer diagnoses may be associated with a strong hereditary component. Micro-RNAs and Long Non-coding RNAs are a group of a noncoding small molecule, which play critical roles in signalling pathways, metabolism, apoptosis and cancer development. Exercising a meta-analysis to examine the relationship between rs3746444, rs3787016 and prostate cancer (PCa) risk was the main objective of our study. Results 10 case-control studies were included, while 6 on rs3787016 and 4 on rs3746444. On the whole, the genotypes carrying the T allele, in which were verified an increased risk between rs3787016 and PCa risk.( T vs C: odds ratio(OR) = 1.802, 95% CI 1.015–3.198, P value of heterogeneity(PH) = 0.00%; CT vs CC: OR = 1.179,95% CI 1.091–1.275, PH = 0.41; TT vs CC: .OR = 1.418, 95% CI 1.229–1.636, PH= 0.961; TT + CT vs CC: OR = 1.216, 95% CI 1.129–1.310, PH= 0.408; TT vs CT + CC: OR = 1.328, 95%CI 1.159–1.521, PH = 0.987). A vital relevance was performed by this meta-analysis in three models between rs3746444 and PCa risk, in which a tendency of increased PCa risk could be found (C vs T: OR = 1.197, 95% CI 1.035–1.384, PH= 0.837; CC vs TT: OR = 1. 137, 95% CI 0.813–1.590, PH = 0.392; CC + CT vs TT: OR = 1.426, 95% CI 1.166–1.743, PH= 0.406.). Conclusion Our findings proposed that rs3746444 in MiRNA-499 and rs3787016 in Long Non-coding RNAs POLR2E polymorphisms increased the risk of developing PCa. Further functional studies are warranted to reveal the role of the polymorphism in carcinogenesis.

show abstract

“…The expression and function of lncRNAs could be affected by genetic variations in the lncRNAs gene. In this regard, numerous investigations have examined the re-lationship between the POLR2E rs3787016 polymorphism and various cancers, including squamous cell carcinoma (ESCC) (23), prostate (20)(21)(22)24), thyroid (26), breast (27,28), cervical (28), liver, and lung cancer (25). In the current study, we conducted a meta-analysis to address the precise role of POLR2E rs3787016 in overall cancer susceptibility.…”

Section: Discussionmentioning

confidence: 99%

“…The POLR2E LncRNA gene is mapped to chromosome 19 (19p13). Several investigations have focused on identifying a relationship between the POLR2E rs3787016 polymorphism and the risk of cancer in various populations (20)(21)(22)(23)(24)(25)(26)(27)(28), but, overall, the findings have been inconsistent and conflicting. To comprehensively assess the correlation between the POLR2E rs3787016 polymorphism and cancer susceptibility, we designed and performed the current meta-analysis.…”

Section: Contextmentioning

confidence: 99%

Association between Long Non-coding RNA POLR2E rs3787016 Polymorphism and Cancer Susceptibility: A Meta-analysis of 8725 Cancer Cases and 10710 Controls

2020

View full text Add to dashboard Cite

Objectives: Several studies have reported a correlation between the POLR2E rs3787016 polymorphism and cancer development, but findings are inconsistent. Therefore, we designed the current study to understand how rs3787016 polymorphism impacts cancer susceptibility. Methods: We searched the Scopus, Web of Science, and PubMed databases for studies related to the topic of interest published up to March 2019. A total of 11 relevant studies, encompassing 8,761 cancer cases and 10,534 controls, were retrieved and subject to quantitative analysis. The strength of the relationship was evaluated using the pooled odds ratios (ORs) with 95% confidence intervals (CIs). Results: Overall, the findings proposed a positive association between rs189037 polymorphism and susceptibility to cancer in homozygous (OR = 1.32, 95% CI = 1.11 - 1.57, P = 0.002, TT vs. CC), recessive (OR = 1.21, 95% CI = 1.06-1.39, P = 0.005, TT vs. CT + CC), and allele (OR = 1.12, 95% CI = 1.02-1.22, P = 0.021, T vs. C) genetic models. Stratified analysis showed that rs3787016 increased the risk of prostate and breast cancer. In addition, we found a significant association between the variant and increased cancer risk in Asian and Caucasian populations. Conclusions: In summary, the findings of the current meta-analysis suggest that the POLR2E rs3787016 polymorphism is an indicator of cancer susceptibility.

show abstract

The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer

Cited by 16 publications

References 22 publications

Autophagy-related long non-coding RNA signature for potential prognostic biomarkers of patients with cervical cancer: a study based on public databases

Autophagy-related long non-coding RNA signature for potential prognostic biomarkers of patients with cervical cancer: a study based on public databases

Association of rs3746444 in MiRNA-499 and rs3787016 in Long Non-coding RNAs POLR2E with Prostate Cancer: an updated meta-analysis and systematic review

Association between Long Non-coding RNA POLR2E rs3787016 Polymorphism and Cancer Susceptibility: A Meta-analysis of 8725 Cancer Cases and 10710 Controls

Contact Info

Product

Resources

About